Data-Driven Discovery: The Role of AI & Emerging Tools in AMD disease prognosis
Time: 1:00 pm
day: Day2
Details:
- Discussing how AI and machine learning models are applied differently in preclinical screening versus clinical endpoint prediction for dry AMD & geographic atrophy
- Comparing the utility and limitations of AI tools across stages of development, including variability in data sources, translational relevance, and regulatory acceptance
- Highlighting opportunities for AI to streamline the transition between discovery and development — enabling better target selection, patient stratification, and trial enrichment
